If further work with irreversible electroporation refines its capacity for discrete tissue ablation deep within the kidney and adjacent to large blood vessels, and especially if larger tumors can be addressed, then this would be a major step forward in the minimally invasive treatment of localized renal cancer.
Percutaneous irreversible electroporation is showing promise as a novel minimally invasive approach for treating small renal tumors, according to the experience of urologists at the University of Texas Southwestern Medical Center, Dallas.
African-American men with very low-risk prostate cancer being followed on active surveillance are at significantly higher risk for disease upgrading on subsequent biopsy compared to Caucasian men, according to analyses of prospectively collected data from the Johns Hopkins Active Surveillance registry.
Have the stars finally become aligned in such a way that Congress resolves the perennial Medicare physician fee fiasco? The signs seem to point that way.
Analyses of data from the Nationwide Inpatient Sample of the Healthcare Cost and Utilization Project are providing understanding on trends in utilization of simple prostatectomy for treatment of symptomatic BPH and addressing the gap in information about its outcomes.
When choosing a life insurance product, time needs to be spent on the intricacies of how those death benefits pass to the intended heirs, and how your estate is impacted, prior to making the purchase.
The Painters clear up confusion surrounding coding for prostate needle biopsy, and also discuss split billing for urodynamics testing.
Neither option will sidestep the need for a manual review prior to payment, say Ray Painter, MD, and Mark Painter.
A recent UCLA study suggests that physicians need to improve treatment counseling for patients with prostate cancer, a leading expert says.
Catch up on February’s best-read Urology Times articles, including our coverage of the AUA’s recent statement on NPs/PAs, a malpractice case involving removal of a cancer-free testicle, and a Q&A on diversity in urology.
The benefits of robot-assisted partial nephrectomy outweigh the health care and surgical costs, a new study found.
Earlier, more aggressive radiation therapy is recommended in prostate cancer patients with detectable PSA following radical prostatectomy, say the authors of a recently published study.
The muddy waters of patient selection and timing of post-prostatectomy radiation therapy may be clearer. Find out how.
A newer androgen receptor blocker significantly increases survival versus a first-generation agent in men with metastatic castration-resistant prostate cancer, data show.
Urologists attending the 2015 Urology Joint Advocacy Conference will have the opportunity to make their voices heard on Capitol Hill at a pivotal time for physicians.
Blood vessel calcification may increase risk of heart disease in patients with recurrent kidney stones, according to a recent study.
Two advisers to Urology Times are among the 2015 AUA annual award recipients.
The adage, “If at first you don’t succeed, try, try again,” does not appear to hold true when it comes to anticholinergic drug use in overactive bladder patients with urinary incontinence, recent study results indicate.
This article provides a real-world definition of refractory overactive bladder and its prevalence, then examines treatment options, with a focus on percutaneous tibial nerve stimulation as a noninvasive form of neuromodulation “for the masses.”
The analysis looked at intracytoplasmic sperm injection use and reproductive outcomes between 1996 and 2012. fertilization. Learn why
A literature review has found no evidence that testosterone therapy increases cardiovascular risk.
A patient with an abnormal PSA level transferred to another physician's care and was never told of his result. Two and a half years later, a biopsy revealed Gleason 9 prostate cancer.
Use of the urethral lift as a treatment for BPH provided rapid improvement in symptoms, flow, and quality of life that were sustained at 2 years in a multicenter study.
While questions and concerns about the use of advanced practice providers (APPs) in urology remain, the AUA's new consensus statement on the use of APPs provides a best practices framework for urology practices. Here are eight take-homes from the statement.
Advanced practice providers should be viewed as skilled members of a health care team who are filling a vital need, writes Urology Times Group Content Director Richard R. Kerr.
A large-scale study provides new evidence that targeted MRI ultrasound fusion prostate biopsy increases detection of high risk prostate cancers while decreasing detection of low-risk cancers. "More reliable diagnosis"
In this blog post, Dr. Henry Rosevear ponders the relationship between drug reps and urologists.
A newly published analysis “opens a huge opportunity for the discovery of new biomarkers” for multiple cancers, including aggressive prostate cancer, a leading urologic cancer expert says.
More than 90% of men whose lower urinary tract symptoms (LUTS) progress do not seek treatment for their symptoms, according to recent study results that one expert cautioned against overinterpreting.